Conferences - Results from #820

Viewing 821-840 of 11869 articles

EAU 2024: Synchronous mHSPC: What are the Treatment Options and What Are the Goals of Treatment? What Is the Evidence for Surgery?

EAU 2024: Synchronous mHSPC: What Are the Treatment Options and What Are the Goals of Treatment? What Is the Evidence for Systemic Therapy in Synchronous Low-Volume mHSPC

EAU 2024: Living with a Prostate Cancer Patient: Real-World Evidence from the Unprecedented Europa Uomo Prostate Cancer Partners in Europe Research (EU-ProPER) Study

EAU 2024: Does Scalpel Play a Role in Intermediate Risk Metastatic RCC? dCN

EAU 2024: Adjuvant Immunotherapy After pT3a F IV /N0 at Nephrectomy: Is That Real High-Risk for All? No

EAU 2024: Does Scalpel Play a Role in Intermediate Risk Metastatic RCC? Upfront CN

EAU 2024: State-of-the-Art Lecture: Staging High-Risk Prostate Cancer with PSMA PET: Strengths and Pitfalls

EAU 2024: Efficacy of Transrectal and Transperineal Prostate Biopsy in Detecting Clinically Significant Prostate Cancer: Results of the ProBE-PC Randomised Clinical Trial

EAU 2024: Risk Adapted Screening for Prostate Cancer in Europe: PSA + MRI + Targeted Biopsies Only (Gothenburg-2 Trial)

EAU 2024: Risk Adapted Screening for Prostate Cancer in Europe: PSA + MRI (OPT - the Swedish Nationwide Screening Strategy)

EAU 2024: Synchronous mHSPC: What Are the Treatment Options and What Are the Goals of Treatment? What Is the Evidence for Radiotherapy

EAU 2024: PARP-Inhibitors Only for Patients with Alterations in DNA Repair Genes: No

EAU 2024: Urological Follow-up of Lynch Syndrome: Upper Tract Urothelial Carcinoma Incidence and Mutational Patterns in a Dedicated Outpatient Clinic

EAU 2024: Photodynamic Diagnosis (PDD) Directed Biopsies vs White Light Bladder Mapping in Patients with Positive Cytology and Negative Preoperative Workup: An International Multicenter Retrospective Study

EAU 2024: First Results of NURE-Combo: A Phase 2 Study of Neoadjuvant Nivolumab Nab-Paclitaxel Followed by Postsurgical Adjuvant Nivolumab in Patients with Muscle-Invasive Bladder Cancer

European Association of Urology (EAU) 2024 Congress Features New Data on Modern Technology Use in Bladder Cancer Care

EAU 2024: Adjuvant Immunotherapy After pT3a F IV /N0 at Nephrectomy: Is That Real High-Risk for All? Yes

EAU 2024: PARP-Inhibitors Only for Patients with Alterations in DNA Repair Genes: The Guidelines' View

EAU 2024: PARP-Inhibitors Only for Patients with Alterations in DNA Repair Genes: Yes

EAU 2024: Intraductal Prostate Cancer Affinity for Lymphatic-Predominant Metastases Through 18F-DCFPyL-PSMA-PET/CT Scans in Pre-Treatment Prostate Cancer Patients

37
38
39
40
41
42
43
44
45
46